OpenAI acquires Orchestra Bio to bring AI agents into drug development

OpenAI Group PBC revealed today that it has acquired drug development software startup Orchestra Bio Inc. Orchestra builds artificial intelligence agents that help pharmaceutical teams keep development programs on track,. Its staff and technology will now sit inside OpenAI’s Rosalind life sciences unit. Much of OpenAI’s case for the deal comes down to how long…